
    
      This trial will be conducted in order to provide an evaluation of the potential of
      ferumoxytol to cause cardiac arrhythmia in accordance with the International Conference on
      Harmonization (ICH) E14 guidance. The purpose of this trial is to define the effects of
      ferumoxytol on electrocardiogram (ECG) data. Pharmacokinetics will also be evaluated at
      multiple time points as specified. Subject safety will be monitored throughout the study.
    
  